Editor's key points † Continuous measurement of beat-to-beat arterial pressure (AP) during the dynamic phases of anaesthesia facilitates recognition and treatment of acute variations. † The non-invasive AP monitor Nexfin TM was compared with invasive AP (IAP) measurements during induction of anaesthesia. † Nexfin TM reliably and quickly detected acute changes in AP, but its accuracy was insufficient to replace IAP monitoring.
† The non-invasive AP monitor Nexfin TM was compared with invasive AP (IAP) measurements during induction of anaesthesia. † Nexfin TM reliably and quickly detected acute changes in AP, but its accuracy was insufficient to replace IAP monitoring.
Background. Standard non-invasive arterial pressure (AP) measurements are discontinuous. By providing non-invasive beat-to-beat AP measurements, Nexfin TM might limit duration of intraoperative hypotension and hypertension. We assessed the ability of Nexfin TM to detect AP variations by comparing its trending ability with invasive AP monitoring.
Methods. Thirty-one subjects undergoing elective surgery under general anaesthesia were included. During induction, simultaneous pairs of AP measurements were collected every 5 s from the Nexfin TM finger sensor and a homolateral radial artery catheter. Magnitude and time lags of AP variations from baseline to nadir and peak were calculated for both methods. Concordance analysis was performed by the Bland-Altman method (for comparison of repeated measures when appropriate).
Results. Nexfin
TM detected 100% of AP changes with the median delays of 0 s (213 to 7) and 0 s (25 to 12) for nadir and peak, respectively. Bias [limits of agreement (LOA)] of systolic AP (SAP) variations was 20.5 mm Hg (231.2 to 30.2) and 29.4 mm Hg (231.3 to 12.6) from baseline to nadir and from baseline to peak, respectively. For 3479 analysed paired measurements, bias was 23.8 and 28.8 mm Hg for SAP and diastolic AP, with LOA of (236.0 to 28.5) and (229.8 to 12.3), respectively.
Conclusions. Nexfin
TM detects AP variations accurately and can be a useful warning device during anaesthesia. However, it is not interchangeable with invasive monitoring, given the large LOA between the two measurements.
Clinical trial registration. NCT01658631.
Keywords: anaesthesiology; arterial pressure monitors; monitoring, intraoperative Accepted for publication: 4 December 2013 During general anaesthesia, invasive arterial pressure (IAP) monitoring remains a standard of care in high-risk patients or in the case of high-risk surgery. In other cases, that is, most of the anaesthetic cases, arterial pressure (AP) is measured every 3-5 min, using an oscillometric AP device as recommended by the ASA 1 and the Association for Advancement of Medical Instrumentation (AAMI). 2 Devices allowing continuous beat-to-beat non-invasive measurement of AP (NIAP) could be particularly useful in a large proportion of patients who experience unpredictable anaesthesia-induced haemodynamic disturbance. Such devices based on the volume-clamp method were developed many years ago 3 and used particularly for physiological studies. 4 5 More recently, several have been introduced for routine use during anaesthesia and intensive care. Among them, the Nexfin TM (BMEYE B.V., Amsterdam, The Netherlands), using photoplethysmographic technology, provides non-invasive beat-to-beat AP readings via a single finger-cuff and is easy to use.
While the induction period of anaesthesia is associated with higher risk of unstable AP than the maintenance period, validation studies of Nexfin TM in children 6 7 and adults 8 -11 (iii) history of Raynaud syndrome and related diseases, cardiac arrhythmia, or vascular surgery of upper extremities, (iv) propensity to hand ischaemia in the presence of radial arterial obstruction as evidenced by a positive Allen test (defined clinically as a lack of return of colour within 7 s after the release of ulnar artery compression or by using a Doppler as a lack of palmar arcade flow detection, while the radial artery is compressed).
Nexfin HD technique
The Nexfin TM is a non-invasive beat-to-beat AP measurement device based on the so-called 'vascular unloading' principle. Finger cuff pressure is continuously adjusted through the systolic AP (SAP) and diastolic AP (DAP) cycle so that the blood volume flowing through the finger arteries is held constant. Thus, cuff pressure is used to indirectly measure finger AP and an algorithm converts the raw beat-to-beat finger AP into brachial AP. 12 
Study protocol
All subjects were orally premedicated with hydroxyzine (1 mg kg 21 ) 1 h before the induction of anaesthesia. Upon admission in the operating theatre, standard monitoring was applied and a 20 G intra-arterial catheter (Leadercath 20G, Vygon, Ecouen, France) was inserted in the non-dominant arm radial artery under local anaesthesia. The catheter was then connected, using standard low compliant tubing, to a disposable pressure transducer (Edwards Lifesciences, Irvine, CA, USA) and placed at the heart level with the patient in the supine position. The transducer was first zeroed to ambient air pressure, and the line was subsequently flushed with a 300 mm Hg pressurized bag of normal saline to remove air bubbles. To test the adequacy of the pressure monitoring system, a rapid flush test was performed as described by Gardner 13 and Kleinman and colleagues. 14 With this test, an under-damped (extra oscillations) or over-damped (slowed upstroke and loss of oscillations) pressure system can be identified. The IAP measurement was checked for quality by visually inspecting the waveform. Continuous NIAP was measured on the same arm with the Nexfin TM device. After choosing the appropriate size, the Nexfin TM finger cuff was applied to the middle phalanx of the second or third finger. The heart reference system was placed at the heart level to measure and correct the hydrostatic pressure difference between the finger and the heart. Then, the finger cuff and the heart reference system were connected to a wrist-processing unit, which was in turn connected to the device. The automatic calibrating procedure of the Nexfin TM device was started, and frequently activated at the start of the measurement. IAP transducer and Nexfin TM were linked via an analogue input to a monitoring system (S5 TM monitor; Datex-Ohmeda, Helsinki, Finland) allowing simultaneous measurements of NIAP and IAP signals. Finally, the monitoring system was connected via an RS 232 port, to the ToolBox 95 version 4.8 recording system. 15 When a stable signal was detected by both AP measurement methods, anaesthesia was induced either manually [sufentanil (0.2 -0.5 mg kg 21 ) and propofol (2-4 mg kg
or by using propofol and remifentanil target-controlled infusion. 16 Tracheal intubation was facilitated by a nondepolarizing neuromuscular blocking drug (atracurium 0.5 mg kg 21 ), and mechanical ventilation was started using the volume-controlled mode. Oxygen-air mixture and ventilation variables were adjusted to maintain pulse oximeter oxygen saturation .96% and end-tidal carbon dioxide partial pressure between 4.39 and 5.06 kPa. Vasoactive drugs were used in order to maintain mean AP (MAP) .65 mm Hg.
Recorded data and analyses
Paired values of SAP, DAP, and MAP obtained by both methods were recorded from 1 min before the induction to 10 min after tracheal intubation. Each stored AP value represented an average of all AP values measured over the previous 5 s period. Signals recorded during Nexfin TM recalibration were not taken into account. Arterial line recordings were visually inspected for any artifacts such as damping or flushing and artifacts were manually removed.
The precision of IAP monitoring was calculated as described previously (2×coefficient of variation of n averaged measurements/ p n) 17 using the 1 min measurements preceding induction of anaesthesia. For each subject and for each method, we determined (i) baseline values of SAP, MAP, and DAP as the 30 s average of their values recorded immediately before induction, and (ii) the minimal (nadir) and maximal (peak) values of AP observed during induction. This allowed calculating differences between the methods concerning (i) values of DAP nadir (i.e. difference between baseline and nadir) and DAP peak (i.e. difference between peak and nadir), and (ii) time to reach nadir and peak pressures (T nadir and T peak, respectively).
Statistical analysis
Comparison of trending analysis ability of both AP measurement methods was performed using a five-pronged strategy.
Four-quadrant plot 18 permits the calculation of the percentage of concordance between changes in AP. Bias and limits of agreement (LOA) were defined as the mean difference between IAP and Nexfin TM measurements and as the range within which 95% of these differences are expected to lie, respectively. The standard Bland -Altman approach 19 was used to analyse agreement for individual AP nadir, AP peak, DAP nadir, and DAP peak values. The BlandAltman approach for repeated measurements, 20 which is appropriate and usable for analyses of unequal number of collected points, was used to study agreement between all paired values (n¼3479). The Wilcoxon rank test was used to compare times to reach nadir and peak pressures.
The polar plot approach was also used. In this method, first proposed to describe trending ability of cardiac output monitors, 21 the bias becomes the mean of the polar angles, the Bland and Altman horizontal limit lines are replaced by radial LOA, and the 308 radial sector lines provide envelopes within which most of the data points should lie if acceptable trending ability exists. Time point analysis to check deviation over time, from 1 min before induction, that is, T21, to 9 min after, that is, T9, was performed using analysis of variance (ANOVA) for repeated measurements.
Finally, as described by Ilies and colleagues, 22 the percentage error (PE) initially developed for cardiac output monitoring device comparison was adapted and used as an interchangeability criterion between IAP and NIAP values. 17 23 Results are expressed as median (first quartile -third quartile), mean (SD), or counts and percentages. A two-sided P-value of 0.05 was considered significant. All analyses were performed with R 2.13.0 statistical software (R Foundation for Statistical Computing, Vienna, Austria).
Results
Thirty-eight subjects were included in the study. As reported in the flow chart (Fig. 1) , the data for seven subjects were excluded from the analysis because of technical or operational problems. 24 In two subjects, the finger cuff malfunctioned and could not inflate; in another, we were unable to obtain a reliable photoplethysmographic signal, despite multiple attempts with different sized cuffs on different fingers; in two subjects, radial artery catheterization was impossible; finally, for two patients, there was a recording system dysfunction. Thus, data from 31 subjects [14 males, median age 63 yr, range (24 -89 yr)] were available for analysis. The main characteristics of these subjects and vasoactive drug requirements are reported in Table 1 . No complications related to the use of the Nexfin TM device or to radial artery catheterization were observed over the study period. We expected to obtain 4092 pairs of data, but actually acquired only 3925 pairs because of minor deviations from protocol (Fig. 1) . Four hundred and forty-six pairs of measurements were deleted because of artifacts (11.3%): removals of 326 (8.3%) and 120 (3%) pairs of measurements were related to Nexfin TM recalibration and to damping and flushing of the arterial catheter, respectively (Fig. 1) . Thus, a total of 3479 valid pairs of simultaneous Nexfin TM and IAP measurements were analysed. The median number of paired measurements per subject was 106 (87.5 -132).
Values of precision for IAP monitoring were 5.4%, 5.1%, and 7.1% for SAP, MAP, and DAP, respectively.
As displayed using the four-quadrant concordance plot in Figure 2 , the percentage of concordance between changes in invasive and non-invasive SAP and DAP was 100%.
Bias and LOA between the two methods for individual nadir values were 21.3 mm Hg (228.1 to 25.4) for SAP, 27 mm Hg (223.5 to 9.7) for DAP, and 24.3 mm Hg (223.2 to 14.5) for MAP. Concerning peak values, bias and LOA for SAP, DAP, and MAP were 210.2 mm Hg (260.4 to 39.9), 212.6 mm Hg (247 to 21.8), and 212.6 mm Hg (249.7 to 24.6), respectively. Times to reach nadir and peak with the two methods were similar (P¼0.2 and 0.58, respectively). The median time lags between both methods to reach nadir and peak values were, respectively, 0 s (213 to 7) and 0 s (25 to 12); they are pictured by box plot representation in Figure 3 . Agreement for individual values of AP variation magnitude (DSAP, DMAP, and DDAP) obtained by the two methods during induction of general anaesthesia is displayed by the Bland -Altman graphical representation in Figure 4 (Fig. 4A for nadir variations and Fig. 4B for peak variations). Finally, bias and LOA between the two methods over all pairs of measurements of SAP, MAP, and DAP are depicted in the modified Bland -Altman plots for repeated measurements (Fig. 5) .
Polar plot results are as follows: polar concordance rate at 308 was 88%, mean angular bias for DSAP and DDAP were 128(18) and 48 (17) , respectively, and radial LOA were 2198 to 358 for DSAP and 2228 to 238 for DDAP (Fig. 6) .
Bias and LOA of SAP, MAP, and DAP at the different time points (T21 to T9) and also results from ANOVA for repeatedmeasures are displayed in Table 2 . We found no significant difference of the mean bias between T21 and T9.
PE values were, respectively, 34%, 37%, and 32% for SAP, DAP, and MAP.
Discussion
Our high vasoactive drug requirement rate (58.1% and 9.7% for ephedrine and phenylephrine, respectively) demonstrates that even among low-risk patients (87% ASA I and II), acute AP variations are common during induction of general anaesthesia. In this context, Nexfin TM was reliable in detecting AP variations rapidly and thus, might be a useful warning device during general anaesthesia. However, Nexfin
TM is not precise enough to measure the magnitude of AP variations accurately and cannot be considered interchangeable with a radial artery catheter for AP measurements during induction of general anaesthesia, given the large LOA between the two types of device.
Acute periods of unstable AP are particularly important in anaesthesia practice as several studies have shown that their early detection and management can impact patient outcome. 25 -28 By providing continuous AP monitoring, Nexfin TM can reduce this delay, but its ability to detect AP variations has never been compared with the gold standard method of AP monitoring, that is, IAP. Indeed, since its commercialization, the Nexfin TM device has been validated during adult anaesthesia by Martina and colleagues and Fischer and colleagues on 9000 and 220 measurements, respectively. However, these studies were performed during periods of relative haemodynamic stability: in the first study, AP values from acute unstable periods were combined with data obtained from prolonged stable periods and the second study was performed in an intensive care unit. For these reasons, we were interested in investigating the trending ability of Nexfin TM . As reflected by four-quadrant plot and 308 polar concordance rates, Nexfin TM reliably detects AP changes and correctly assesses their direction. Furthermore, Nexfin TM instantly viewed these variations, as shown by the ,1 s detection time-lag with the arterial line. Finally, feasibility and safety of the Nexfin TM device seems to be satisfactory as we report a lower failure rate of Nexfin TM than in previous studies and no complications related to its use. 10 11 However, concerning variation magnitude detection, although bias values were acceptable, LOA between the reference method and Nexfin TM were too wide to be considered as suitable for clinical practice. Moreover, using the limits of the polar approach proposed by Critchley and colleagues 21 for evaluating devices measuring cardiac output, we report a high angular bias and large radial LOA. However, using Critchley's limits can be questioned. Interestingly, concerning agreement between the two methods over all pairs of measurements, our results do not confirm those of Martina and colleagues 11 and Fischer and colleagues. 10 Indeed, width of agreement limits do not allow Nexfin TM to fulfil AAMI validation criteria. Furthermore, the PE for SAP, MAP, and DAP was also too high to conclude that there was interchangeability between Nexfin TM and IAP. 22 Unlike a recent study from Hohn and colleagues 29 evaluating Nexfin TM in critically ill patients, we did not show any effect of measurement time on Nexfin accuracy. As explained above, these discrepancies might be due to different study periods. In our study, haemodynamic instability and sudden changes in vascular tone could have required further recalibration of the Nexfin TM device, thus increasing the relative imprecision of this non-invasive technique. Indeed, Nexfin TM 'Physiocal' software is in charge of calibrations and periodic adjustment to vasomotor changes, but it is based on an algorithm. Furthermore, two other studies have previously reported such an effect of haemodynamic disturbances and vasoactive drug requirements on accuracy of continuous non-invasive finger AP monitoring. Ilies and colleagues 22 have already reported that the PE of Cnap TM , another NIAP monitoring device based on the 'volume clamp method', was much higher during the unstable period of anaesthesia induction than during maintenance of anaesthesia. More recently, Hohn and colleagues 29 showed a low accuracy of Nexfin TM monitoring in critically ill patients since they reported that bias, precision, and LOA between invasive and non-invasive MAP were 6 (12) and 218 to +30 mm Hg with similar results whether patients received norepinephrine infusion or not.
The accuracy of our reference method, IAP, should also be discussed. When using this method, an awareness and understanding of the common sources of errors-primarily resonance, damping, and errors of zeroing and levelling-and how to detect and to prevent these errors is important to ensure accurate and useful measurement. In our study, several steps were taken in order to limit these sources of error: use of a highfrequency transducer and stiff, non-compliant, ,100 cm, and large diameter tubing; direct connection of the tubing to the cannula; careful flush of air bubbles from the system before data collection; regular square wave tests (i.e. fast flush tests) for each patient, ensuring the signal was interpretable; 13 14 and choice of the widely used midpoint of the right atrium reflecting cardiac preload as the reference level. Paying attention to these precautions, we found that IAP monitoring was precise. Nevertheless, the use of the radial artery catheter as reference method still results in a major limitation. Indeed, whereas our reference method measures radial AP, the Nexfin TM device has an algorithm software that allows the real-time conversion of measured finger AP into a reconstructed brachial artery waveform. However, from the brachial to the radial measurement site, narrowing of arteries has been shown to enhance AP reflection, which results in an increase in SAP and a decrease in DAP. 30 This so-called pulse pressure amplification phenomenon could have biased our results. For this reason, the AAMI standard for the evaluation of NIAP devices clearly states that if IAP measurements are compared with non-invasive finger devices, the radial artery should not be used as the reference device, since a systematic bias has to be expected. 2 However, for ethical reasons, IAP measurement in the subclavian, axillary, or brachial arteries was not possible in our study.
In conclusion, our study shows that the Nexfin TM device detects AP variations reliably and quickly and could be a useful warning device during induction of general anaesthesia. Thus, Nexfin TM might limit duration of hypotensive or hypertensive events and play a role in the case of impossible arterial catheterization for anatomical, technical, or organizational reasons, which accounted for 5% of cases in our study. However, the accuracy of Nexfin TM measurements of AP variation magnitude is not to consider this device interchangeable with IAP monitoring. Finally, Nexfin TM does not satisfy AAMI validation criteria during acute periods of unstable AP.
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